Lloyd Kersh Medical Services Ltd 12486827 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is Locum General Practitioner Digita Accounts Production Advanced 6.30.9574.0 true true 12486827 2022-03-01 2023-02-28 12486827 2023-02-28 12486827 bus:OrdinaryShareClass1 2023-02-28 12486827 bus:OrdinaryShareClass2 2023-02-28 12486827 core:CurrentFinancialInstruments 2023-02-28 12486827 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 12486827 bus:SmallEntities 2022-03-01 2023-02-28 12486827 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 12486827 bus:AbridgedAccounts 2022-03-01 2023-02-28 12486827 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 12486827 bus:RegisteredOffice 2022-03-01 2023-02-28 12486827 bus:Director1 2022-03-01 2023-02-28 12486827 bus:Director2 2022-03-01 2023-02-28 12486827 bus:OrdinaryShareClass1 2022-03-01 2023-02-28 12486827 bus:OrdinaryShareClass2 2022-03-01 2023-02-28 12486827 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12486827 countries:AllCountries 2022-03-01 2023-02-28 12486827 2021-03-01 2022-02-28 12486827 2022-02-28 12486827 bus:OrdinaryShareClass1 2022-02-28 12486827 bus:OrdinaryShareClass2 2022-02-28 12486827 core:CurrentFinancialInstruments 2022-02-28 12486827 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12486827

Lloyd Kersh Medical Services Ltd

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 28 February 2023

 

Lloyd Kersh Medical Services Ltd

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 6

 

Lloyd Kersh Medical Services Ltd

Company Information

Directors

Mr L Kersh

Mrs V L Kersh

Registered office

57 Trevean Way
Newquay
Cornwall
TR7 1TW

Accountants

Harland Accountants
Ground Floor, Unit 3 Southview House
St Austell Enterprise Park
Carclaze Down
St Austell
Cornwall
PL25 4EJ

 

Lloyd Kersh Medical Services Ltd

(Registration number: 12486827)
Abridged Balance Sheet as at 28 February 2023

Note

2023
£

2022
£

Current assets

 

Debtors

-

2,241

Cash at bank and in hand

 

11,476

13,439

 

11,476

15,680

Creditors: Amounts falling due within one year

(2,204)

(2,844)

Total assets less current liabilities

 

9,272

12,836

Accruals and deferred income

 

(1,200)

(1,140)

Net assets

 

8,072

11,696

Capital and reserves

 

Called up share capital

4

101

101

Retained earnings

7,971

11,595

Shareholders' funds

 

8,072

11,696

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

Lloyd Kersh Medical Services Ltd

(Registration number: 12486827)
Abridged Balance Sheet as at 28 February 2023

Approved and authorised by the Board on 13 November 2023 and signed on its behalf by:
 

.........................................

Mr L Kersh

Director

 

Lloyd Kersh Medical Services Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The company ceased trading on the 02 February 2023 and will apply to be struck off is due course, following Companies House guidelines.

The address of its registered office is:
57 Trevean Way
Newquay
Cornwall
TR7 1TW

These financial statements were authorised for issue by the Board on 13 November 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Lloyd Kersh Medical Services Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2023

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Lloyd Kersh Medical Services Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 28 February 2023

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2022 - 0).

4

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

1

1

1

1

 

101

101

101

101